AMEH - Apollo Medical sinks despite upbeat guidance

Despite better-than-expected Q4 2021 financials and favorable 2022 outlook, Apollo Medical Holdings (AMEH -9.9%) is on track to record its biggest intraday loss since December after the medical care service provider failed to indicate EBITDA estimates for the year. The management said that outlook only included revenue estimates “due to uncertainties related to its participation in a Centers for Medicare & Medicaid Services Innovation Center ("CMMI") innovation model.” In addition, the ongoing investments in labor and certain investment activities subject to macro factors have also prompted the change, the company added. In November, Apollo Medical (NASDAQ:AMEH) revised its 2021 EBITDA guidance to $139M – $143M from $100M – $119M.  For the full year, the company reported $174.2M of EBITDA, indicating ~34% YoY growth from 2020. However, Barclays analyst Sarah James noted that the company’s inclusion in a key 2022 list of Medicare contractors removes one of the major overhangs for the

For further details see:

Apollo Medical sinks despite upbeat guidance